Browse > Article

Comparison of Femoropopliteal Bypass and Superficial Femoral Artery Stenting for Treating Femoral Artery Occlusive Disease  

Lee, Gun (Department of Thoracic and Cardiovascular Surgery, Bundang CHA General Hospital, College of Medicine, Pochon CHA University)
Lim, Chang-Young (Department of Thoracic and Cardiovascular Surgery, Bundang CHA General Hospital, College of Medicine, Pochon CHA University)
Kim, Man Deuk (Department of Diagnostic Radiology, Bundang CHA General Hospital, College of Medicine, Pochon CHA University)
Lee, Hyeon-Jae (Department of Thoracic and Cardiovascular Surgery, Bundang CHA General Hospital, College of Medicine, Pochon CHA University)
Publication Information
Journal of Chest Surgery / v.42, no.1, 2009 , pp. 53-58 More about this Journal
Abstract
Background: The goal of this study was to compare the patency and complications of femoropopliteal bypass with superficial femoral artery stenting for patients with atherosclerotic superficial femoral artery occlusive disease. Material and Method: Between July 2005 and July 2008, we reviewed 29 femoropopliteal bypass procedures (24 patients) with prosthetic grafts (the bypass group) and 19 superficial femoral artery stentings (15 patients) with nitinol stent (the stent group). There were 35 male patients (89.7%) and the mean age of the patients was 69.2 years (range: 48~84). The number of patients who had DM, hypertension and a smoking history was 25 patients (64.1%), 17 patients (43.6%) and 30 patients (76.9%), respectively. 23 (59.0%) patients had skin ulceration or tissue gangrene at admission. Result: There were 27 cases (93.0%) of TASC C&D lesion in the bypass group and 16 cases (84.2%) of TASC A&B lesion in the stent group. There were significant differences for the indications for a procedure between the two groups (p<0.01). The primary patency rates at 6 months, 12 months and 24 months were 91.9%, 79.7% and 79.7% for the bypass group and 93.3%, 86.2% and 86.2% for the stent group, respectively. There were no statistical difference between the two groups (p=0.48). Conclusion: There were no significant differences in the outcome between two groups. TASC C&D lesion and failed intervention therapy should be treated with femoropopliteal bypass surgery, and TASC A&B lesion and the high-risk patients should be treated with femoral artery stent insertion.
Keywords
Peripheral vascular disease; Atherosclerosis; Stents; Bypass surgery;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Sabeti S, Shillinger M, Amighi J, et al. Primary patency of femoropopliteal arteries treated with Nitinol versus stainless steel self expanding stents: propensity score-adjusted analysis. Radiology 2004;232:516-21   DOI   ScienceOn
2 Schermerhorn ML, Cronenwett JL, Baldwin JC. Open surgical repair versus endovascular therapy for chronic lower-extremity occlusive disease. Annu Rev Med 2003;54: 269-83   DOI   ScienceOn
3 Park KH. Endovascular treatment of iliac & femoral artery occlusive disease. J Korean Soc Vasc Surg 2008;24:72-5
4 Matsi PJ, Manninen HI, Vanninen RL, et al. Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1-3 year follow-up. Radiology 1994;191:727-33   DOI
5 Patterson R, Pinto B, Marcus B, et al. Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg 1997;25:312-9   DOI   ScienceOn
6 Klinkert P, Schepers A, Burger DH, et al. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting, five year results of a randomzed controlled trial. J Vasc Surg 2003;37:149-55   DOI   ScienceOn
7 Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-296   DOI   ScienceOn
8 Dawson D, Cutler B, Meissner M, et al. Cilostazol has beneficial effects in treatment of intermittent claudication. Circulation 1998;98:678-86   DOI   ScienceOn
9 Surowiec SM, Davis MG, Eberly SW, et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 2005;41:269-78   DOI   ScienceOn
10 Sala F, Hassen-Khodja R, Lecis A, et al. Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts. Ann Vasc Surg 2003;17:401-7   DOI   ScienceOn
11 Dormandy T, Heeck L, Vig S. Peripheral arterial occlusive disease. Clinical data for decision making. Semin Vasc Surg 1999;12:93-162
12 Post S, Kraus T, Muller-Reinartz U, et al. Dacron vs polytetrafluoroethylene grafts for femoro-popliteal bypasses; a prospective randomized multicentre trial. Eur J Vasc Surg 2001;22:226-31   DOI   ScienceOn